Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplant
NCT00309907Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Apr 2006
- Primary completion
- Sep 2011
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in Idiopathic Pneumonia Syndrome (IPS), sponsored by Children's Oncology Group. Started Apr 2006; status: completed.
02
Drugs
etanercept
03
Conditions
Idiopathic Pneumonia Syndrome (IPS)
Beyond the preview
Go deeper on NCT00309907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309907.